September 01, 2014 10:10 PM ET

Pharmaceuticals

Company Overview of Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc.

Company Overview

As of September 23, 2013, Aurinia Pharmaceuticals Inc. was acquired by Isotechnika Pharma Inc. Aurinia Pharmaceuticals Inc. operates a clinical stage pharmaceutical company which focuses on the global nephrology market. The company holds the license for voclosporin in lupus nephritis. Aurinia Pharmaceuticals Inc. is based in Victoria, Canada.

4464 Markham Street

Suite 1203

Victoria, BC V8Z7X8

Canada

Phone:

250-744-2488

Fax:

250-744-2498

Key Executives for Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc.

Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc. does not have any Key Executives recorded.

Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc. Key Developments

Aurinia Pharmaceuticals Presents at The 11th Annual BIO Investor Forum 2012, Oct-09-2012 11:30 AM

Aurinia Pharmaceuticals Presents at The 11th Annual BIO Investor Forum 2012, Oct-09-2012 11:30 AM. Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Boehringer Ingelheim (Canada) Ltd./Ltée. Americas
MMJ Bioscience Inc. Americas
Theralipids, Inc. Americas
4everPets Ltd. Americas
Vetech Laboratories, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aurinia Pharmaceuticals Inc. Prior To Merger With Isotechnika Pharma Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.